The agreement covers kinetoplastid diseases (leishmaniases, Chagas disease, and human African trypanosomiasis), helminth infections (lymphatic filariasis, onchocerciasis, and soil-transmitted helminthiasis), and dracunculiasis, fascioliasis, and schistosomiasis diseases. Under the
Earlier, Johns Hopkins University has licensed FP01 intellectual property to Fells Labs. As per the terms of the current agreement, Fells Labs is entitled to get an upfront
The CBORD Group, which operates as a unit of Roper Industries, serves healthcare facilities, colleges and universities, chain restaurants, supermarkets, senior living facilities, corporations, and a host of
As per the terms of the agreement, ProMetic will be responsible to accelerate an affinity resin product and associated manufacturing process conditions for its client. The agreement will
Dificid tablets are indicated for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age or older. The FDA approval was given on the basis
The high dose cohort (3 mg/kg/dose) Phase II trial expects to recruit around 21 patients in the trial. The company anticipates to release the top line results of
Paras Pharmaceuticals’ personal care business includes brands such as Recova, Setwet, Zatak, Borosoft, Livon, Moov, Krack, ItchGuard, RingGuard and Dermicool etc. RB, which is keen to focus on
The lawsuit seeks to stop Vi-Jon from violating P&G’s intellectual property and selling the infringing products. The lawsuit alleges that Vi-Jon is violating P&G’s intellectual property by manufacturing
SPRIX, which uses an Aptar Pharma nasal spray pump, is a non-invasive treatment for pain management. Aptar Pharma worked closely with Roxro Pharma for over 7 years to
Krystexxa is indicated as a treatment for chronic gout in adult patients refractory to conventional therapy. The MAA was submitted on the basis of safety and efficacy data
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.